Vaughan Nelson Investment Management L.P. increased its position in shares of Fabrinet (NYSE:FN – Free Report) by 52.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 28,944 shares of the technology company’s stock after purchasing an additional 9,935 shares during the period. Vaughan Nelson Investment Management L.P.’s holdings in Fabrinet were worth $15,095,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently bought and sold shares of FN. Price T Rowe Associates Inc. MD increased its holdings in shares of Fabrinet by 163.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 4,041,227 shares of the technology company’s stock worth $1,839,891,000 after buying an additional 2,504,841 shares during the last quarter. Wasatch Advisors LP grew its position in Fabrinet by 45.1% in the second quarter. Wasatch Advisors LP now owns 1,779,665 shares of the technology company’s stock worth $524,432,000 after acquiring an additional 553,196 shares during the period. Norges Bank acquired a new stake in Fabrinet during the fourth quarter worth $193,766,000. JPMorgan Chase & Co. raised its position in Fabrinet by 64.8% in the fourth quarter. JPMorgan Chase & Co. now owns 1,065,414 shares of the technology company’s stock valued at $485,063,000 after purchasing an additional 419,081 shares during the period. Finally, Alliancebernstein L.P. lifted its stake in shares of Fabrinet by 226.1% in the 3rd quarter. Alliancebernstein L.P. now owns 499,177 shares of the technology company’s stock valued at $182,010,000 after purchasing an additional 346,113 shares during the last quarter. 97.38% of the stock is currently owned by institutional investors and hedge funds.
Fabrinet Stock Performance
Shares of FN opened at $617.84 on Tuesday. Fabrinet has a 1 year low of $262.20 and a 1 year high of $748.89. The stock has a market capitalization of $22.14 billion, a PE ratio of 53.08 and a beta of 1.18. The stock has a 50-day simple moving average of $660.88 and a 200-day simple moving average of $559.64.
Insider Activity
In other news, Director Homa Bahrami sold 2,500 shares of the stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $711.91, for a total value of $1,779,775.00. Following the transaction, the director owned 16,233 shares in the company, valued at approximately $11,556,435.03. This represents a 13.35% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.24% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on the company. Fox Advisors downgraded Fabrinet from a “strong-buy” rating to an “equal weight” rating in a research report on Tuesday, May 5th. Weiss Ratings raised shares of Fabrinet from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, June 15th. Northland Securities set a $800.00 price objective on shares of Fabrinet in a report on Monday, April 20th. Barclays lifted their target price on shares of Fabrinet from $548.00 to $702.00 and gave the company an “overweight” rating in a report on Tuesday, May 5th. Finally, Needham & Company LLC restated a “buy” rating and set a $800.00 price target on shares of Fabrinet in a research note on Tuesday, May 5th. Six research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $661.75.
Check Out Our Latest Research Report on FN
Fabrinet Company Profile
Fabrinet is a global provider of advanced optical packaging and precision optical, electro‐mechanical and electronic manufacturing services (CEM). The company specializes in complex manufacturing processes for original equipment manufacturers (OEMs) in communications, data center, industrial, instrumentation and medical markets. Key capabilities include high‐precision fiber alignment, micro‐assembly, testing and diagnostics, and integration of electro‐optic subassemblies.
Incorporated in 2000, Fabrinet operates under a corporate structure headquartered in Singapore with additional regional offices and design centers in the Americas, Europe and Asia.
See Also
- Five stocks we like better than Fabrinet
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Want to see what other hedge funds are holding FN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fabrinet (NYSE:FN – Free Report).
Receive News & Ratings for Fabrinet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fabrinet and related companies with MarketBeat.com's FREE daily email newsletter.
